CoreWeave, Inc. (CRWV) Insider Transactions
Explore official ownership filings, with every record linked to its source.
CRWV · CoreWeave, Inc.
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. F13 The reported securities are directly held of record by the reporting person's child. F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025. This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3. References: F1, F6, F3 | S Sale (market/private)Class A Common Stock · Non-derivative | 31D | 93.179 | IndirectCanis Major SM Trust | Form 4 ↗0001769628-26-000305 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. F13 The reported securities are directly held of record by the reporting person's child. F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025. This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3. References: F1, F5, F3 | S Sale (market/private)Class A Common Stock · Non-derivative | 64D | 92.0602 | IndirectCanis Major SM Trust | Form 4 ↗0001769628-26-000305 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. F13 The reported securities are directly held of record by the reporting person's child. F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025. This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3. References: F1, F4, F3 | S Sale (market/private)Class A Common Stock · Non-derivative | 31D | 91.399 | IndirectCanis Major SM Trust | Form 4 ↗0001769628-26-000305 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. F13 The reported securities are directly held of record by the reporting person's child. F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025. This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3. References: F1, F2, F3 | S Sale (market/private)Class A Common Stock · Non-derivative | 23D | 90.227 | IndirectCanis Major SM Trust | Form 4 ↗0001769628-26-000305 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F1, F13 | C Other reported codeClass B Common Stock · Derivative | 12,500D | — | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F1, F12 | C Other reported codeClass B Common Stock · Derivative | 40,000D | — | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F1, F2 | C Other reported codeClass B Common Stock · Derivative | 3,000D | — | IndirectCanis Major 2024 Irrevocable Trust LLC | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 125D | 98.31 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F11, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 275D | 97.0029 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F10, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 956D | 96.0746 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F9, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 5,933D | 95.3757 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F8, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 1,506D | 94.278 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F7, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 767D | 93.1725 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F6, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 1,606D | 92.0589 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F5, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 757D | 91.4047 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F4, F13 | S Sale (market/private)Class A Common Stock · Non-derivative | 575D | 90.2431 | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F1, F13 | C Other reported codeClass A Common Stock · Non-derivative | 12,500A | — | IndirectCanis Minor 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 400D | 98.31 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F11, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 880D | 97.0029 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F10, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 3,061D | 96.075 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F9, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 18,987D | 95.3757 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F8, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 4,815D | 94.278 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F7, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 2,456D | 93.1726 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F6, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 5,140D | 92.059 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
| 2026-06-29Filed 2026-07-01 | McBee BranninOfficer · Chief Development OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. F2 The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. F12 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. F13 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person are continued on Part 3. References: F3, F5, F12 | S Sale (market/private)Class A Common Stock · Non-derivative | 2,420D | 91.4047 | IndirectCanis Major 2025 GRAT | Form 4 ↗0001769628-26-000302 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.